Home

JOSEPH M LEONE

CIK 1176381 · Vice Chairman and CFO · last filed 2017-07-05

JOSEPH M LEONE is a Vice Chairman and CFO who has filed 35 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for ALQA, was dated Jul 5, 2017. Across all open-market trades the lifetime net is −$9.5M, making them a net seller over the disclosed history. 43 SEC filings were submitted jointly with CIT GROUP INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

35

Lifetime Open-Market Net

-$9.49M

Filer Profile

Related Filers
CIT GROUP INC — 43 joint filings, latest 2010-04-29
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Alliqua BioMedical, Inc. (ALQA) Delisted Director 7,304 — — $19.7K 6 2017-07-05
CIT GROUP INC (CIT) Delisted Vice Chairman and CFO 3,380 $53.50 $180.9K -$9.51M 22 2010-04-29

Recent Filings

35 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-07-05 Alliqua BioMedical, Inc. (ALQA) Delisted Grant (A) — $0 EDGAR
2017-04-04 Alliqua BioMedical, Inc. (ALQA) Delisted Buy (P) +25,000 $10.0K EDGAR
2016-05-13 Alliqua BioMedical, Inc. (ALQA) Delisted Grant (A) — $0 EDGAR
2015-11-09 Alliqua BioMedical, Inc. (ALQA) Delisted Buy (P) +3,500 $9.7K EDGAR
2015-05-08 Alliqua BioMedical, Inc. (ALQA) Delisted Grant (A) — $0 EDGAR
2014-03-10 Alliqua BioMedical, Inc. (ALQA) Delisted Grant (A) — $0 EDGAR
2013-07-02 — Mixed +123,457 $0
2013-02-26 — Mixed +246,914 $0
2013-02-26 — Grant (A) — $0
2013-02-26 — Buy (P) +300,000 $0
Showing 1–10 of 35
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.